How do I use the bilirubin nomogram (Bhutani hour‑specific chart) to determine risk levels for a newborn based on total serum bilirubin and exact age in hours?

How to Use the Bilirubin Nomogram to Determine Risk Levels

Measure the total serum bilirubin (TSB) or transcutaneous bilirubin (TcB), determine the infant's exact age in hours (not days), plot this value on the Bhutani hour-specific nomogram, and identify which of the four risk zones the value falls into—this single measurement predicts the likelihood of developing severe hyperbilirubinemia and dictates follow-up timing and phototherapy decisions. 1

Step-by-Step Application of the Nomogram

1. Determine Patient Eligibility

• The Bhutani nomogram applies specifically to infants ≥35 weeks gestational age with birth weight ≥2500g, or infants ≥36 weeks gestational age with birth weight ≥2000g 2, 3
• Do not use this nomogram for infants <35 weeks gestation or those below the weight thresholds 2

2. Obtain Accurate Bilirubin Measurement

• Measure TSB or TcB before discharge, ideally at the time of routine metabolic screening to avoid an additional blood draw 1
• Never rely on visual assessment alone—this leads to dangerous errors, particularly in darkly pigmented infants 1, 4
• If jaundice appears in the first 24 hours or appears excessive for age, measure bilirubin immediately regardless of discharge timing 2, 4

3. Calculate Exact Age in Hours

• Always use the infant's age in hours, never in days—this is a critical and common error that leads to inappropriate risk stratification 2, 3
• Calculate from the time of birth to the time of bilirubin measurement 1

4. Plot the Value on the Nomogram

• Place the bilirubin value (y-axis) at the corresponding age in hours (x-axis) on the Bhutani nomogram 1
• The nomogram displays percentile curves that divide infants into four distinct risk zones 2, 3

5. Identify the Risk Zone

The nomogram stratifies infants into four zones based on where the plotted value falls 2, 3:

High-Risk Zone (≥95th percentile)

• These infants are at highest risk for developing severe hyperbilirubinemia 1
• Require immediate intervention and close follow-up within 24 hours of discharge 4, 3
• Consider starting phototherapy based on age-specific treatment nomograms 3

High-Intermediate Risk Zone (75th-94th percentile)

• Moderate risk for progression to severe hyperbilirubinemia 2
• Require follow-up within 24-48 hours after discharge 2
• Monitor closely for rising bilirubin 2

Low-Intermediate Risk Zone (40th-74th percentile)

• Lower but still present risk for significant hyperbilirubinemia 2
• Require follow-up within 48-72 hours 2
• Standard monitoring protocols apply 2

Low-Risk Zone (<40th percentile)

• Very low risk of developing severe hyperbilirubinemia 1
• Routine follow-up based on discharge timing is sufficient 2, 4
• Negative predictive value exceeds 90% 1

Critical Risk Factors That Modify Management

Even with nomogram-based risk stratification, certain clinical features increase the likelihood of severe hyperbilirubinemia and warrant heightened surveillance 1:

Major Risk Factors

• Predischarge bilirubin in the high-risk zone on the nomogram 1
• Jaundice observed in the first 24 hours of life—this is always pathologic and demands immediate TSB measurement and workup 1, 4
• Blood group incompatibility with positive direct antiglobulin test (ABO or Rh) or other hemolytic disease 1
• G6PD deficiency—occurs in 11-13% of African Americans and was responsible for 31.5% of kernicterus cases in one series 1, 2
• Gestational age 35-36 weeks 1
• Previous sibling who received phototherapy 1
• Cephalohematoma or significant bruising 1
• Exclusive breastfeeding with poor nursing and excessive weight loss 1
• East Asian race 1

Minor Risk Factors

• Gestational age 37-38 weeks 1
• Jaundice observed before discharge (but after 24 hours) 1
• Previous sibling with jaundice 1
• Macrosomic infant of diabetic mother 1
• Male gender 1

Follow-Up Timing Based on Discharge Age

The American Academy of Pediatrics provides specific follow-up schedules that must be followed regardless of nomogram zone 1, 3:

• Discharged before 24 hours: Follow-up by 72 hours of age 1
• Discharged between 24-47.9 hours: Follow-up by 96 hours of age 1
• Discharged between 48-72 hours: Follow-up by 120 hours of age 1

Infants with risk factors or elevated bilirubin zones require earlier or more frequent follow-up than these minimum standards 1, 3

When to Obtain Laboratory Workup

Beyond the nomogram, certain clinical scenarios demand additional testing 2, 4, 3:

• Jaundice in first 24 hours: Obtain TSB, blood type and Coombs test, complete blood count with smear, direct/conjugated bilirubin, reticulocyte count, and G6PD level 2, 4
• Rapidly rising bilirubin (≥0.2 mg/dL/hour after 24 hours or ≥0.3 mg/dL/hour in first 24 hours): Same workup as above 2, 4, 3
• Bilirubin approaching exchange transfusion levels or failing to respond to phototherapy: Add G6PD testing if not already done 2, 3
• Severe hyperbilirubinemia in high-risk ethnic groups (Mediterranean, Middle Eastern, African, Asian): Test for G6PD deficiency 2, 4

Common Pitfalls to Avoid

Critical Errors in Nomogram Use

• Never use days instead of hours when plotting values—this is the most common and dangerous error 2, 3
• Never discharge an infant with jaundice in the first 24 hours without measuring bilirubin and establishing a clear follow-up plan 4
• Never rely on visual assessment to estimate bilirubin levels, especially in darkly pigmented infants 1, 4

G6PD-Specific Pitfalls

• A normal G6PD level during active hemolysis does not exclude deficiency—reticulocytes have higher enzyme activity and can mask the diagnosis; repeat testing at 3 months if clinical suspicion persists 2, 4
• Use lower phototherapy and exchange transfusion thresholds in G6PD-deficient infants due to increased risk of kernicterus 2

Treatment Errors

• Do not subtract direct bilirubin from total bilirubin when making phototherapy decisions 4
• Do not supplement breastfed infants with water or dextrose water 4
• If appropriate follow-up cannot be ensured and risk factors are present, delay discharge until 72-96 hours when peak risk has passed 1

Linking Nomogram Results to Treatment Decisions

Once you've identified the risk zone, use age-specific and risk-stratified phototherapy nomograms to determine treatment thresholds 4, 3:

• Low-risk infants (≥38 weeks, well, no risk factors): Use standard phototherapy curve 4
• Medium-risk infants (≥38 weeks with risk factors OR 35-37 6/7 weeks, well): Use medium-risk curve with lower thresholds 4
• High-risk infants (35-37 6/7 weeks with risk factors): Use high-risk curve with lowest thresholds 4

Phototherapy should produce a bilirubin decrease >2 mg/dL within 4-6 hours if effective 3